Autism-Mitochondrial Dysfunction Link: 1 in 200 At Risk
Posted: Mon Jun 04, 2007 11:45 am
I decided not to respond to most of the ridiculousness posted on this thread over the weekend, but I'm in a cheery mood this morning. So I'll note two things:
(1) I do know people how have survived for "very long" after chemo.
(2) Studies of intravenous vitamin C have shown some promise (as far as whether it's "better" than chemo, I can't say), as the blood levels of the vitamin are quite high. Oral vitamin C has been well studied and has shown no benefit whatsoever. I agree that further studies are needed, especially since there's likely to be a large population of patients with relapsed cancer who might not want to undergo another round of chemo.
(3) I agree that direct advertisement of prescription drugs ought to be banned again. It's proven to be a gigantic disaster.
(4) Re: DCA: Evangelos Michelakis recently published a study in a peer-reviewed journal noting the apparent promise of DCA. You're right that Big Pharma has no interest in funding his planned bigger studies, so he's raising the funds himself. However, he's also deeply concerned about the spread of news/hysteria re: DCA on the internet, because it's apparently leading people to formulate and use the compound outside of the context of a controlled trial. Here's what he said of it in Science:
(1) I do know people how have survived for "very long" after chemo.
(2) Studies of intravenous vitamin C have shown some promise (as far as whether it's "better" than chemo, I can't say), as the blood levels of the vitamin are quite high. Oral vitamin C has been well studied and has shown no benefit whatsoever. I agree that further studies are needed, especially since there's likely to be a large population of patients with relapsed cancer who might not want to undergo another round of chemo.
(3) I agree that direct advertisement of prescription drugs ought to be banned again. It's proven to be a gigantic disaster.
(4) Re: DCA: Evangelos Michelakis recently published a study in a peer-reviewed journal noting the apparent promise of DCA. You're right that Big Pharma has no interest in funding his planned bigger studies, so he's raising the funds himself. However, he's also deeply concerned about the spread of news/hysteria re: DCA on the internet, because it's apparently leading people to formulate and use the compound outside of the context of a controlled trial. Here's what he said of it in Science:
Michelakis and other researchers are worried by the development. Although DCA seems safe overall, they point to a clinical trial that was stopped early because those taking the drug developed damage to their peripheral nerves (P. Kaufmann et al. Neurology 66, 324–330; 2006). Without a control group, they point out, it will be impossible to tell whether any improvement in the patients' condition is caused by the drug. Patients could also be taking DCA that is not of pharmaceutical grade and might contain harmful impurities.
Michelakis says the patients could end up undermining efforts to do a controlled clinical trial if, for example, some develop harmful side effects and the drug earns a bad reputation. "It's destroying efforts to do this right," he says. "Any way you look at this, it's a negative development." An FDA spokesperson told Nature that the agency is looking into the matter.